Articles with "nvaf patients" as a keyword



Photo from wikipedia

Association between activated partial thromboplastin time, age and bleeding events in NVAF patients receiving dabigatran

Sign Up to like & get
recommendations!
Published in 2018 at "European Journal of Clinical Pharmacology"

DOI: 10.1007/s00228-018-2583-5

Abstract: PurposeThe purpose of this study was to analyze the association between bleeding events and coagulation assays including activated partial thromboplastin time (APTT) and prothrombin time (PT), and to determine the risk factors for bleeding in… read more here.

Keywords: risk; nvaf patients; bleeding events; age ... See more keywords
Photo by sammiechaffin from unsplash

Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.

Sign Up to like & get
recommendations!
Published in 2019 at "Thrombosis and haemostasis"

DOI: 10.1055/s-0038-1676818

Abstract: BACKGROUND  There have been no prior nationwide reports on the prevalence of hypertrophic cardiomyopathy (HCM) among patients suffering from atrial fibrillation (AF). It is also unclear how much stroke risk is attributable to HCM compared… read more here.

Keywords: nvaf patients; stroke risk; prevalence; hcm ... See more keywords
Photo by sharonmccutcheon from unsplash

P3815Cost and burden of poor control of the level of anticoagulation in patients with non-valvular atrial fibrillation treated with vitamin K antagonist in the Spanish National Health Service

Sign Up to like & get
recommendations!
Published in 2019 at "European Heart Journal"

DOI: 10.1093/eurheartj/ehz745.0657

Abstract: Poorly controlled non-valvular atrial fibrillation (NVAF) patients treated with vitamin K antagonists (VKA) experience higher rates of clinical events compared to well controlled patients. In Spain a high percentage of NVAF patients present an inadequate… read more here.

Keywords: anticoagulation; nvaf patients; control; clinical events ... See more keywords
Photo by finnnyc from unsplash

Direct Oral Anticoagulants and Mortality in Atrial Fibrillation

Sign Up to like & get
recommendations!
Published in 2018 at "Blood"

DOI: 10.1182/blood-2018-99-111182

Abstract: Background Direct oral anticoagulants (DOACs) are at least as effective as vitamin K antagonists (VKAs) for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). DOACs are associated with less intracranial hemorrhage and are easier… read more here.

Keywords: therapy; nvaf patients; doac therapy; mortality ... See more keywords